BioAtla Inc.

30.51-0.7400-2.37%Vol 152.58K1Y Perf -1.82%
Sep 24th, 2021 16:00 DELAYED
BID30.51 ASK30.59
Open30.84 Previous Close31.25
Pre-Market- After-Market-
 - -  - -%
Target Price
75.25 
Analyst Rating
— — 0.00
Potential %
146.64 
Finscreener Ranking
 —    -
Insiders Trans % 3/6/12 mo.
-/-/- 
Value Ranking
★★★+     53.77
Insiders Value % 3/6/12 mo.
-/-/- 
Growth Ranking
 —    -
Insiders Shares Cnt. % 3/6/12 mo.
-/-/- 
Income Ranking
 —    -
Price Range Ratio 52W %
6.79 
Earnings Rating
Market Cap1.03B 
Earnings Date
12th Nov 2021
Alpha0.11 Standard Deviation0.14
Beta-3.16 

Today's Price Range

30.2131.28

52W Range

27.1576.63

Summary:

Sell

Technical Indicators: Neutral
Moving Averages: Strong Sell
Performance
1 Week
-11.69%
1 Month
-25.22%
3 Months
-28.63%
6 Months
-49.76%
1 Year
-1.82%
3 Years
-
5 Years
-
10 Years
-

TickerPriceChg.Chg.%
BCAB30.51-0.7400-2.37
AAPL146.920.09000.06
GOOG2 852.6616.13000.57
MSFT299.35-0.2100-0.07
XOM57.590.51000.89
WFC47.920.12000.25
JNJ164.36-0.5000-0.30
FB352.967.00002.02
GE103.800.84000.82
JPM163.041.86001.15
Earnings HistoryEstimateReportedSurprise %
Q02 2021-0.56-0.90-60.71
Q01 2021-0.48-0.56-16.67
----
----
----
----
----
----
Earnings Per EndEstimateRevision %Trend
----
----
----
----
Next Report Date12th Nov 2021
Estimated EPS Next Report-0.92
Estimates Count3
EPS Growth Next 5 Years %-
Volume Overview
Volume152.58K
Shares Outstanding33.81M
Shares Float25.20M
Trades Count2.30K
Dollar Volume22.18M
Avg. Volume243.98K
Avg. Weekly Volume329.81K
Avg. Monthly Volume356.05K
Avg. Quarterly Volume241.95K

BioAtla Inc. (NASDAQ: BCAB) stock closed at 30.51 per share at the end of the most recent trading day (a -2.37% change compared to the prior day closing price) with a volume of 152.58K shares and market capitalization of 1.03B. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Biotechnology industry, Healthcare sector and employs 36 people. BioAtla Inc. CEO is Jay M. Short.

The one-year performance of BioAtla Inc. stock is -1.82%, while year-to-date (YTD) performance is %. BCAB stock has a five-year performance of %. Its 52-week range is between 27.15 and 76.63, which gives BCAB stock a 52-week price range ratio of 6.79%

BioAtla Inc. currently has a PE ratio of -8.10, a price-to-book (PB) ratio of 6.56, a price-to-sale (PS) ratio of 2 606.23, a price to cashflow ratio of -, a PEG ratio of 2.32, a ROA of -35.58%, a ROC of -43.25% and a ROE of -43.31%. The company’s profit margin is -%, its EBITDA margin is -18 951.30%, and its revenue ttm is $400.00 Thousand , which makes it $0.01 revenue per share.

Of the last four earnings reports from BioAtla Inc., there were 0 positive earnings surprise and 2 negative earnings surprise. The company has EPS estimate of $-0.92 for the next earnings report. BioAtla Inc.’s next earnings report date is 12th Nov 2021.

The consensus rating of Wall Street analysts for BioAtla Inc. is (), with a target price of $, which is 0.00% compared to the current price. The earnings rating for BioAtla Inc. stock is (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).

BioAtla Inc. has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.

BioAtla Inc. has a Sell technical analysis rating based on Technical Indicators (ADX : 33.89, ATR14 : 2.05, CCI20 : -139.35, Chaikin Money Flow : -0.47, MACD : -2.55, Money Flow Index : 17.51, ROC : -19.14, RSI : 24.99, STOCH (14,3) : 10.84, STOCH RSI : 0.24, UO : 25.09, Williams %R : -89.16), Simple Moving Averages and Exponential Moving Averages.

Aggregated Insider Trades of BioAtla Inc. in the last 12-months were:

Analyst RatingsCurrent1 M ago3 M ago
Strong Buy
0
0
0
Moderate Buy
0
0
0
Hold
0
0
0
Moderate Sell
0
0
0
Strong Sell
0
0
0
Summary Rating---

BioAtla Inc.

BioAtla Inc is a clinical-stage biopharmaceutical company. The company is engaged in the development of a novel class of highly specific and selective antibody-based therapeutics for the treatment of solid tumor cancer.

CEO: Jay M. Short

Telephone: +1 858 558-0708

Address: 11085 Torreyana Road, San Diego 92121, CA, US

Number of employees: 36

Bearish or Bullish?
WeekMonthThree MonthsSix Months

Bearish Bullish

50%50%

Bearish Bullish

69%31%

Bearish Bullish

59%41%

Bearish Bullish

67%33%

TipRanks News for BCAB

Wed, 08 Sep 2021 07:04 GMT Taking Stock of BioAtlas Risk Factors

- TipRanks. All rights reserved.

News

Stocktwits